Compass Pathways PLC
Change company Symbol lookup
Select an option...
CMPS Compass Pathways PLC
NEOV NeoVolta Inc
SYBX Synlogic Inc
FIISO Financial Institutions Inc
KA Kineta Inc
TCS Container Store Group Inc
MLGO MicroAlgo Inc
INDI indie Semiconductor Inc
JCI Johnson Controls International PLC
FPAY FlexShopper Inc

Health Care : Biotechnology |
Based in United Kingdom
Company profile

COMPASS Pathways plc is a United Kingdom-based mental healthcare company. The Company is developing psilocybin therapy through late-stage clinical trials in Europe and North America for patients with treatment-resistant depression (TRD). The Company has developed COMP360, which is a psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin. The Company's COMP360 has completed a Phase IIb clinical trial of psilocybin therapy for TRD, in 22 sites across Europe and North America. This trial assessed the safety and efficacy of COMP360 psilocybin therapy in three doses: 1mg, 10mg, 25mg. The Company is also running a Phase II clinical trial of COMP360 psilocybin therapy for anorexia nervosa and post-traumatic stress disorder (PTSD). The Company is also developing its investigational COMP360 psilocybin therapy for the treatment of a range of mental health conditions, with an initial focus on TRD.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
Day's Change
-0.10 (-1.26%)
B/A Size
Day's High
Day's Low

10-day average volume:
  • Prev Close
  • Today's Open
  • Day's Range
  • Avg Vol (10-day)
  • Last (time)
    4:00p ET 09/22/23
  • Last (size)
  • 52-Wk Range
    6.97 - 12.88
  • (09/22/22 - 01/06/23)
  • 65.7%
  • Market Cap
  • Shares Outstanding
  • -2.35
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 27.14
  • (% of float 08/31/23)

Latest News

September 19, 2023
8:02 am ET
PR Newswire
September 18, 2023
4:31 pm ET
Globe Newswire
September 08, 2023
8:55 am ET
September 06, 2023
4:00 am ET
Globe Newswire
August 29, 2023
4:30 pm ET
Globe Newswire
August 16, 2023
8:58 am ET
Globe Newswire
August 03, 2023
7:00 am ET
Globe Newswire
July 31, 2023
8:32 am ET
Globe Newswire
July 27, 2023
9:31 am ET
PR Newswire
July 26, 2023
9:31 am ET
PR Newswire
8:45 am ET
PR Newswire
July 25, 2023
4:00 am ET
Globe Newswire
July 17, 2023
4:00 am ET
Globe Newswire
July 13, 2023
4:00 am ET
Globe Newswire
July 07, 2023
9:31 am ET
PR Newswire
July 06, 2023
7:00 am ET
Globe Newswire
July 05, 2023
7:00 am ET
Globe Newswire
June 23, 2023
11:15 am ET
May 26, 2023
10:28 am ET
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.